Chemical structure of tirapazamine.
Find information on thousands of medical conditions and prescription drugs.

Tirapazamine

Tirapazamine (SR-4233) is an experimental anticancer drug that is activated to a toxic radical only at very low levels of oxygen (hypoxia). Such levels are common in human solid tumors, a phenomenon known as tumor hypoxia. Thus, tirapazamine is activated to its toxic form preferentially in the hypoxic areas of solid tumors. Cells in these regions are resistant to killing by radiotherapy and most anticancer drugs. Thus the combination of tirapazamine with conventional anticancer treatments is particularly effective. As of 2006, tirapazamine is undergoing phase III testing in patients with head and neck cancer, and similar trials are being undertaken for other solid tumor types. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
Oxytetracycline
Phentermine
Tacrine
Tacrolimus
Tagamet
Talbutal
Talohexal
Talwin
Tambocor
Tamiflu
Tamoxifen
Tamsulosin
Tao
Tarka
Taurine
Taxol
Taxotere
Tazarotene
Tazobactam
Tazorac
Tegretol
Teicoplanin
Telmisartan
Temazepam
Temocillin
Temodar
Temodar
Temozolomide
Tenex
Teniposide
Tenoretic
Tenormin
Tenuate
Terazosin
Terbinafine
Terbutaline
Terconazole
Terfenadine
Teriparatide
Terlipressin
Tessalon
Testosterone
Tetrabenazine
Tetracaine
Tetracycline
Tetramethrin
Thalidomide
Theo-24
Theobid
Theochron
Theoclear
Theolair
Theophyl
Theophyl
Theostat 80
Theovent
Thiamine
Thiomersal
Thiopental sodium
Thioridazine
Thorazine
Thyroglobulin
Tiagabine
Tianeptine
Tiazac
Ticarcillin
Ticlopidine
Tikosyn
Tiletamine
Timolol
Timoptic
Tinidazole
Tioconazole
Tirapazamine
Tizanidine
TobraDex
Tobramycin
Tofranil
Tolazamide
Tolazoline
Tolbutamide
Tolcapone
Tolnaftate
Tolterodine
Tomoxetine
Topamax
Topicort
Topiramate
Tora
Toradol
Toremifene
Tracleer
Tramadol
Trandate
Tranexamic acid
Tranxene
Tranylcypromine
Trastuzumab
Trazodone
Trenbolone
Trental
Trest
Tretinoin
Triacetin
Triad
Triamcinolone
Triamcinolone hexacetonide
Triamterene
Triazolam
Triclabendazole
Triclosan
Tricor
Trifluoperazine
Trilafon
Trileptal
Trimetazidine
Trimethoprim
Trimipramine
Trimox
Triprolidine
Triptorelin
Tritec
Trizivir
Troglitazone
Tromantadine
Trovafloxacin
Tubocurarine chloride
Tussionex
Tylenol
Tyrosine
U
V
W
X
Y
Z

Chemically it is an aromatic heterocycle di-N-oxide. Its full chemical name is 3-amino-1,2,4-benzotriazine-1,4 dioxide. Originally it was prepared in a programme screening for new herbicides in 1972. Its clinical use was first described by Zeman et al in 1986.

Read more at Wikipedia.org


[List your site here Free!]



Photochemical electron transfer reactions of tirapazamine
Photochemical Electron Transfer Reactions of Tirapazamine(para) ABSTRACT The absorption and fluorescence spectra of 3-aminobenzo-1,2,4-triazine di-N-oxide ...
Drug strikes tumors other treatments miss - experimental anti-cancer drug tirapazamine destroys tumor cells that resist standard treatments - Brief Article
Researchers are testing a novel anti-cancer drug which strikes only those tumor cells that resist standard treatments. Used in combination with conventional ...
SRI International Celebrates 50 Years of Drug Discovery and Development Contributions; Drugs Discovered, Developed and Tested by SRI Are Improving and
PHILADELPHIA -- SRI International's Biosciences Division, a unique organization that operates as a research-driven pharmaceutical and biotechnology company, a technology incubator, and a full-servi
Research and Markets: Oncology in Big Pharmaceutical Companies
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c12440) has announced the addition of Business Development and R&D ...
Research and Markets: Recent Advances in Field of Oncology by Large Pharmaceutical Companies Analysed
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c12084) has announced the addition of Business Development and R&D ...
Research and Markets: Market Leaders in Oncology 2004 - Roche and Genentech Continue to Blaze a Trail
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c12125) has announced the addition of Market Leaders in Oncology 2004 - Roche and Genentech Continue to Blaze a Tr

Home Contact Resources Exchange Links ebay